NASDAQ
OABIW

OmniAb Inc.

Biotechnology
Healthcare

Prices are adjusted according to historical splits.

OmniAb Inc. Stock Price

Vitals

Today's Low:
$1.14
Today's High:
$1.14
Open Price:
$1.14
52W Low:
$0.2914
52W High:
$1.5
Prev. Close:
$1.16
Volume:
214

Company Statistics

Market Cap.:
$0
Book Value:
Revenue TTM:
$39.01 million
Operating Margin TTM:
-101.25%
Gross Profit TTM:
$0
Profit Margin:
-82.61%
Return on Assets TTM:
-8.37%
Return on Equity TTM:
-13.99%

Company Profile

OmniAb Inc. had its IPO on 2021-09-30 under the ticker symbol OABIW.

The company operates in the Healthcare sector and Biotechnology industry. OmniAb Inc. has a staff strength of 74 employees.

Stock update

Shares of OmniAb Inc. opened at $1.14 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.14 - $1.14, and closed at $1.14.

This is a -1.72% slip from the previous day's closing price.

A total volume of 214 shares were traded at the close of the day’s session.

In the last one week, shares of OmniAb Inc. have slipped by -3.38%.

OmniAb Inc.'s Key Ratios

OmniAb Inc. has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months OmniAb Inc.’s revenue was $39.01 million with a gross profit of $0 and an EBITDA of $-24897000. The EBITDA ratio measures OmniAb Inc.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, OmniAb Inc.’s operating margin was -101.25% while its return on assets stood at -8.37% with a return of equity of -13.99%.

In Q2, OmniAb Inc.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 10.1%.

OmniAb Inc.’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into OmniAb Inc.’s profitability.

OmniAb Inc. stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

OmniAb Inc. stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$405.24 million
Total Liabilities
$24.24 million
Operating Cash Flow
$0
Capital Expenditure
$813000
Dividend Payout Ratio
0%

OmniAb Inc. ended 2024 with $405.24 million in total assets and $0 in total liabilities. Its intangible assets were valued at $405.24 million while shareholder equity stood at $333.81 million.

OmniAb Inc. ended 2024 with $0 in deferred long-term liabilities, $24.24 million in other current liabilities, 12000.00 in common stock, $-9576000.00 in retained earnings and $83.98 million in goodwill. Its cash balance stood at $20.99 million and cash and short-term investments were $103.15 million. The company’s total short-term debt was $3,417,000 while long-term debt stood at $0.

OmniAb Inc.’s total current assets stands at $115.94 million while long-term investments were $0 and short-term investments were $82.16 million. Its net receivables were $8.61 million compared to accounts payable of $2.36 million and inventory worth $0.

In 2024, OmniAb Inc.'s operating cash flow was $0 while its capital expenditure stood at $813000.

Comparatively, OmniAb Inc. paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$1.14
52-Week High
$1.5
52-Week Low
$0.2914
Analyst Target Price
$

OmniAb Inc. stock is currently trading at $1.14 per share. It touched a 52-week high of $1.5 and a 52-week low of $1.5. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $1.04 and 200-day moving average was $0 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About OmniAb Inc.

The stock symbol (also called stock or share ticker) of OmniAb Inc. is OABIW

The IPO of OmniAb Inc. took place on 2021-09-30

Similar Industry Stocks (Biotechnology)

Last Price
Chg
Chg%
$0.06
0
+3.45%
$1.45
0.12
+9.02%
Dr. Lal PathLabs Ltd (LALPATHLAB)
$2205.4
-13.95
-0.63%
$127.6
-0.4
-0.31%
$13.79
0.03
+0.22%
GMS Inc (GMS)
$65.39
0
0%
$4325
-226.75
-4.98%
$4.45
0.21
+4.95%
$60.49
-0.64
-1.05%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company’s discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company’s OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTaur that features unique structural attributes of cow antibodies for complex targets. The company was founded in 2012 and is headquartered in Emeryville, California.

Address

5980 Horton Street, EmeryVille, CA, United States, 94608